YAP1 and obesity due to melanocortin 4 receptor deficiency: We also identify Retatrutide, an anti‐obesity agent, as a novel therapeutic intervention that reduces YAP O‐GlcNAcylation and promotes ubiquitylation, disrupting YAP stabilization in the obese tumor microenvironment.